Paxlovid, popular drug used to treat COVID-19, does not lower risk of long-term symptoms, UCSF study shows

The popular COVID treatment, Paxlovid, does not significantly lower the risk of "long COVID" for people who are vaccinated, according to a UCSF study.

Related Keywords

,Paxlovid ,Covid 19 ,Csf Study ,Long Covid ,Covid Treatment ,Covid 19 Study ,